PSY18 COST-EFFECTIVENESS OF TOFACITINIB IN ACTIVE PSORIATIC ARTHRITIS AFTER ANTI-TUMOUR NECROSIS FACTOR (ANTI-TNF) FAILURE OR INTOLERANCE IN SPAIN
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2646
https://www.valueinhealthjournal.com/article/S1098-3015(19)35024-7/fulltext
Title :
PSY18 COST-EFFECTIVENESS OF TOFACITINIB IN ACTIVE PSORIATIC ARTHRITIS AFTER ANTI-TUMOUR NECROSIS FACTOR (ANTI-TNF) FAILURE OR INTOLERANCE IN SPAIN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)35024-7&doi=10.1016/j.jval.2019.09.2646
First page :
Section Title :
Open access? :
No
Section Order :
12324